No Proof Required
Teva QVAR Inhaler $35M Antitrust Class Action Settlement
✓ Details reviewed against the official QVARAntitrustSettlement.com notice and ClassAction.org reporting · last verified July 23, 2026
Not sure if this settlement applies to you?
Take our 60-second eligibility quiz to find every settlement you qualify for — including this one.
Who Is Eligible?
You may be eligible to file a claim if you:
- You are a consumer or entity (health plan) that purchased or reimbursed some or all of the cost of QVAR or QVAR Redihaler between January 1, 2015 and July 31, 2025.
- Buyers in 43 states are eligible to file.
How Much Can You Get?
Cash payments come from the $35 million fund based on what you paid for QVAR products. Class members with proof of purchase receive a larger share of the net fund; those without proof receive a smaller share. Final amounts depend on total valid claims and deductions for fees and costs.
How this claim was filed
This settlement is closed, so the steps below are kept for reference only — they no longer lead anywhere you can file.
- Confirm eligibility — you bought or reimbursed QVAR/QVAR Redihaler between Jan 1, 2015 and July 31, 2025 in an eligible state.
- File by July 31, 2026 at the official site, QVARAntitrustSettlement.com. Class Action Buddy can auto-fill the form.
- Proof is optional but valuable — pharmacy records, receipts, or an explanation of benefits showing your QVAR purchases qualify you for a larger payment. You can still file without proof for a smaller share.
- Filing is free. (Exclusion/objection deadline was June 15, 2026; final approval hearing Aug 5, 2026.)
Looking for something you can still claim?
This one has closed, but the open settlements list is kept current, and Class Action Buddy will tell you when a new one matches your profile.
Frequently Asked Questions
What is the deadline to file a claim for the Teva QVAR Inhaler $35M Antitrust Class Action Settlement?
The deadline to file a claim was Jul 31, 2026, and it has passed. Claims are no longer accepted for this settlement.
How much can I receive from the Teva QVAR Inhaler $35M Antitrust Class Action Settlement?
The maximum payout per eligible claimant is up to Varies (share of $35M). Actual payments may be lower depending on the total number of valid claims filed and the available settlement fund.
Do I need proof of purchase for the Teva QVAR Inhaler $35M Antitrust Class Action Settlement?
No proof of purchase is required — you can typically file based on a sworn statement, without receipts, photos, or product packaging. Note: some settlements still require a Claimant ID or PIN from a mailed notice; if this one does, it will be shown on the official claim form.
How do I file a claim for the Teva QVAR Inhaler $35M Antitrust Class Action Settlement?
You have two options: (1) Use the free Class Action Buddy mobile app — set up your profile once and the app fills in the official PDF claim form and captures your signature, then your signed claim is printed and posted to the administrator. (2) File directly with the settlement administrator using the official claim form linked on this page.
Who qualifies for the QVAR settlement?
Consumers and health plans in 43 states that purchased or reimbursed QVAR or QVAR Redihaler inhalers between January 1, 2015 and July 31, 2025.
How much does it pay?
A cash share of the $35 million fund based on what you paid. Claimants with proof of purchase receive a larger share; those without proof receive a smaller share.
Do I need proof?
No — you can file without it for a smaller payment. Providing pharmacy records, receipts, or an explanation of benefits qualifies you for a larger share.
What is the deadline?
Claims must be submitted by July 31, 2026.
Ready to File Your Claim?
We're adding new settlements regularly. Download the app to get notified when this one is available.
Download Class Action Buddy →Get Notified About New Settlements
We find new class action settlements every week. Get alerts so you never miss free money.
No spam. Unsubscribe anytime. We respect your privacy.